Levels of Serum IGF-I,MMP-7 and IGFBP-3 in Colorectal Cancer Patients

LIU Tianzhou,WANG Rui
DOI: https://doi.org/10.3969/j.issn.1671-6825.2011.05.023
2011-01-01
Abstract:Aim: To explore the levels of serum insulin-like growth factor-1 (IGF-1),matrix metalloproteinase-7 (MMP-7) and insulin-like growth factor binding protein-3 (IGFBP-3) in colorectal cancer and benign colorectal disease groups,and analyse the relationship between the levels of the protein and chemotherapy efficacy.Methods:Serum IGF-1,MMP-7 and IGFBP-3 were determined by ELISA in 36 colorectal cancer patients (before and after regimen),30 colorectal patients with benign disease and 30 healthy controls.Results:The levels of serum MMP-7 and IGFBP-3 level in colorectal cancer patients before chemotherapy,colorectal benign disease group and healthy control group were obvious different(F=536.940 and 468.740,P0.001).The level of MMP-7 improved and IGFBP-3 dropped in colorectal cancer patients.For those obtaining CR+PR patients,the level of serum MMP-7 decreased obviously(t=6.518,P=0.001),and serum IGFBP-3 increased obviously after chemotherapy(t=18.145,P0.001).For those obtaining SD+PD patients,there was no significant difference among three groups in serum IGF-I,MMP-7 and IGFBP-3 level after chemotherapy(P0.05).Conclusion:MMP-7 decreasing and IGFBP-3 increasing may be used to predict and evaluate the efficacy of chemotherapy.
What problem does this paper attempt to address?